cough sound analysis

Pfizer offers AU$100 million for Australian company that developed COVID-19 cough diagnostic app

By Lynne Minion 03:57 am April 21, 2022

Biopharmaceutical giant Pfizer has offered AU$100 million (US$74.43 million) to acquire Australian company ResApp, which has developed a mobile app to diagnose COVID-19 by the sound of a person's cough. In its announcement of the proposed acquisition to the Australian Stock Exchange, ResApp said Pfizer will acquire 100 per cent of the company's shares following an anticipated positive shareholder...

A person wearing mask is typing on their phone

Smartphone-based COVID-19 detection test from Australia shows high accuracy

By Adam Ang 02:55 am March 22, 2022

ASX-listed digital health firm ResApp Health has announced that its pilot clinical trial for a smartphone-based COVID-19 screening test has achieved positive results. The new diagnostic app, which uses machine learning to analyse the sound of a patient's cough, was reported to correctly detect COVID-19 in 92% of participants with the infection during the trial. With a 92% sensitivity, it exceeds...